Surgical Sutures - Medical Devices Pipeline Assessment, 2017

  • ID: 4318331
  • Report
  • 101 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Ethicon US LLC
  • John Hopkins University
  • MiMedx Group Inc
  • Resorba GmbH
  • Tepha Inc
  • The University of Nort
  • MORE
Surgical Sutures - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Surgical Sutures - Medical Devices Pipeline Assessment, 2017" provides an overview of Surgical Sutures currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Sutures pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Surgical Sutures under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Surgical Sutures and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Surgical Sutures under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ethicon US LLC
  • John Hopkins University
  • MiMedx Group Inc
  • Resorba GmbH
  • Tepha Inc
  • The University of Nort
  • MORE
1 Table of Contents
2 Introduction
2.1 Surgical Sutures Overview
3 Products under Development
3.1 Surgical Sutures - Pipeline Products by Stage of Development
3.2 Surgical Sutures - Pipeline Products by Segment
3.3 Surgical Sutures - Pipeline Products by Territory
3.4 Surgical Sutures - Pipeline Products by Regulatory Path
3.5 Surgical Sutures - Pipeline Products by Estimated Approval Date
3.6 Surgical Sutures - Ongoing Clinical Trials
4 Surgical Sutures - Pipeline Products under Development by Companies
4.1 Surgical Sutures Companies - Pipeline Products by Stage of Development
4.2 Surgical Sutures - Pipeline Products by Stage of Development
5 Surgical Sutures Companies and Product Overview
5.1 Ethicon US LLC Company Overview
5.1.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Innovation Pharmaceuticals Inc Company Overview
5.2.1 Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 John Hopkins University Company Overview
5.3.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.4 MiMedx Group Inc Company Overview
5.4.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Nobles Medical Technology, Inc. Company Overview
5.5.1 Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 NuVascular Technologies Inc Company Overview
5.6.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Resorba GmbH Company Overview
5.7.1 Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.8 Silver Bullet Therapeutics, Inc. Company Overview
5.8.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Tepha Inc Company Overview
5.9.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 The University of North Carolina at Chapel Hill Company Overview
5.10.1 The University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
5.11 TissueGen Inc Company Overview
5.11.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 VitaThreads, LLC Company Overview
5.12.1 VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview
6 Surgical Sutures - Recent Developments
6.1 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund
6.2 Jun 07, 2017: Cellceutix Announces Company Name Change to Innovation Pharmaceuticals
6.3 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress
6.4 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.5 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
6.6 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017
6.7 Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results
6.8 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance
6.9 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board
6.10 Mar 31, 2017: B. Braun continues its sales and earnings growth
6.11 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors
6.12 Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016
6.13 Mar 14, 2017: Arthrex Welcomes Mark Ferguson, MD, as Director of Medical Education, Asia-Pacific (APAC) Region
6.14 Feb 23, 2017: MiMedx Announces 2016 Record Results
6.15 Feb 22, 2017: Change in the B. Braun Management Board
6.16 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.17 Feb 16, 2017: Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones
6.18 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.19 Feb 01, 2017: CONMED Announces Fourth Quarter and Fiscal Year 2016 Financial Results
6.20 Feb 01, 2017: CROMA-PHARMA opens 12th subsidiary in Germany
6.21 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance
6.22 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90%
6.23 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.24 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.25 Nov 14, 2016: Cellceutix Provides Corporate Update and Reports Q1 Fiscal 2017 Financial Results
6.26 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published
6.27 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results
6.28 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results
6.29 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance
6.30 Sep 16, 2016: Cellceutix Announces Appointment of Vice President for Regulatory Affairs
6.31 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.32 Sep 14, 2016: Advanced Medical Solutions Group: Interim Results for the six months ended 30 June 2016
6.33 Sep 13, 2016: Cellceutix Provides Business Update and Timeline of Upcoming Milestones
6.34 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance
6.35 Aug 30, 2016: Cellceutix Further Expands Its Senior Management Team With the Addition of an Industry Veteran
6.36 Aug 30, 2016: Cellceutix Further Expands Its Senior Managment Team With the Addition of an Industry Veteran
6.37 Aug 25, 2016: Medtronic Reports First Quarter Financial Results
6.38 Jul 27, 2016: CONMED Announces Second Quarter 2016 Financial Results
6.39 Jul 26, 2016: MiMedx Announces Second Quarter 2016 Results
6.40 Jul 11, 2016: MiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range
6.41 Jul 07, 2016: MiMedx Adds New Executive
6.42 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
6.43 Jun 30, 2016: Cellceutix Announces Industry Veteran Arthur P. Bertolino, MD, PhD, MBA Joins Company as President and Chief Medical Officer
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Surgical Sutures - Pipeline Products by Stage of Development
Table 2: Surgical Sutures - Pipeline Products by Segment
Table 3: Surgical Sutures - Pipeline Products by Territory
Table 4: Surgical Sutures - Pipeline Products by Regulatory Path
Table 5: Surgical Sutures - Pipeline Products by Estimated Approval Date
Table 6: Surgical Sutures - Ongoing Clinical Trials
Table 7: Surgical Sutures Companies - Pipeline Products by Stage of Development
Table 8: Sutures - Pipeline Products by Stage of Development
Table 9: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Additional PLUS Barbed Suture - Product Status
Table 11: Additional PLUS Barbed Suture - Product Description
Table 12: VICRYL - Next Gen - Product Status
Table 13: VICRYL - Next Gen - Product Description
Table 14: Vicryl Rapide Plus Suture - Product Status
Table 15: Vicryl Rapide Plus Suture - Product Description
Table 16: Ethicon US LLC - Ongoing Clinical Trials Overview
Table 17: Vicryl Rapide Plus Suture - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study
Table 18: VICRYL - Next Gen - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study
Table 19: Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Antimicrobial Suture - Product Status
Table 21: Antimicrobial Suture - Product Description
Table 22: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Drug-Loaded Microfiber Suture - Product Status
Table 24: Drug-Loaded Microfiber Suture - Product Description
Table 25: MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: CollaFix Collagen Fiber Suture - Product Status
Table 27: CollaFix Collagen Fiber Suture - Product Description
Table 28: Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 29: SuperStitch II - Product Status
Table 30: SuperStitch II - Product Description
Table 31: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: NuSpun Arteriovenous Suture - Product Status
Table 33: NuSpun Arteriovenous Suture - Product Description
Table 34: Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 35: RESOCAT CHROM SUTURE - Product Status
Table 36: RESOCAT CHROM SUTURE - Product Description
Table 37: RESOCAT PLAIN - Product Status
Table 38: RESOCAT PLAIN - Product Description
Table 39: SUPRAMID EXTRA SUTURE - Product Status
Table 40: SUPRAMID EXTRA SUTURE - Product Description
Table 41: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Galvanis Suture - Product Status
Table 43: Galvanis Suture - Product Description
Table 44: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: TephaFLEX Absorbable Multifilament Fiber - Product Status
Table 46: TephaFLEX Absorbable Multifilament Fiber - Product Description
Table 47: The University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Angiogenic Suture - Product Status
Table 49: Angiogenic Suture - Product Description
Table 50: TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: ELUTE Fiber - Smart Suture - Product Status
Table 52: ELUTE Fiber - Smart Suture - Product Description
Table 53: VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 54: VitaSuture Wound Management System - Product Status
Table 55: VitaSuture Wound Management System - Product Description
Table 56: Glossary

List of Figures
Figure 1: Surgical Sutures - Pipeline Products by Stage of Development
Figure 2: Surgical Sutures - Pipeline Products by Segment
Figure 3: Surgical Sutures - Pipeline Products by Territory
Figure 4: Surgical Sutures - Pipeline Products by Regulatory Path
Figure 5: Surgical Sutures - Pipeline Products by Estimated Approval Date
Figure 6: Surgical Sutures - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ethicon US LLC
  • Innovation Pharmaceuticals Inc
  • John Hopkins University
  • MiMedx Group Inc
  • Nobles Medical Technology, Inc.
  • NuVascular Technologies Inc
  • Resorba GmbH
  • Silver Bullet Therapeutics, Inc.
  • Tepha Inc
  • The University of Nort
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll